Viking Therapeutics Inc (VKTX) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Rising ...

featured-image

Viking Therapeutics Inc (VKTX) reports significant progress in clinical trials and maintains a strong cash position despite increased R&D and administrative costs.

Viking Therapeutics Inc (VKTX) reports significant progress in clinical trials and maintains a strong cash position despite increased R&D and administrative costs..